Febuxostat induced Stevens Johnson syndrome: A case report

Background: Febuxostat is a novel non-purine selective xanthine oxidase inhibitor with superior ability to lower serum urate levels than allopurinol. Case Report: We report a case of Stevens Johnson syndrome following febuxostat administration. Conclusion: This case report underlines the necessity o...

Full description

Saved in:
Bibliographic Details
Published in:The International journal of risk & safety in medicine 2024-11, Vol.35 (4), p.334-336
Main Authors: Sidhu, Jaspreet K, Chopra, Deepti
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Febuxostat is a novel non-purine selective xanthine oxidase inhibitor with superior ability to lower serum urate levels than allopurinol. Case Report: We report a case of Stevens Johnson syndrome following febuxostat administration. Conclusion: This case report underlines the necessity of recognising this major mucocutaneous adverse reaction and the need for cautious medication usage.
ISSN:0924-6479
1878-6847
DOI:10.1177/09246479241292014